Adcock's Controlling Investor Names Bidvest Executive As New CEO
This article was originally published in PharmAsia News
Executive Summary
Adcock Ingram Holdings quickly replaced former CEO Jonathan Louw, who resigned earlier in the week, with an executive from the same investment company that blocked the proposed sale of the firm to a foreign company.